Mark D. Lanigan

535 total citations
9 papers, 463 citations indexed

About

Mark D. Lanigan is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Mark D. Lanigan has authored 9 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Immunology. Recurrent topics in Mark D. Lanigan's work include Ion channel regulation and function (6 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). Mark D. Lanigan is often cited by papers focused on Ion channel regulation and function (6 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). Mark D. Lanigan collaborates with scholars based in United States, Australia and Germany. Mark D. Lanigan's co-authors include Michael W. Pennington, Raymond S. Norton, K. George Chandy, Heiko Rauer, Michael D. Cahalan, Katalin Kálmán, William R. Kem, Vladimir M. Mahnir, Stephan Grissmer and George A. Gutman and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biopolymers.

In The Last Decade

Mark D. Lanigan

9 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Lanigan United States 8 391 106 98 77 36 9 463
Stéphanie Mouhat France 8 583 1.5× 78 0.7× 374 3.8× 57 0.7× 27 0.8× 8 640
Stephen A. Monks Australia 7 263 0.7× 69 0.7× 83 0.8× 82 1.1× 85 2.4× 10 349
Luz M. Londono United States 4 155 0.4× 15 0.1× 64 0.7× 18 0.2× 31 0.9× 5 235
Matthew D. Fuller United States 11 404 1.0× 126 1.2× 46 0.5× 113 1.5× 2 0.1× 15 516
Xiongzhi Zeng China 12 324 0.8× 32 0.3× 248 2.5× 45 0.6× 16 0.4× 29 398
Kathrin A. Stauffer United Kingdom 10 548 1.4× 50 0.5× 145 1.5× 119 1.5× 3 0.1× 13 662
Carolina Möller United States 12 302 0.8× 6 0.1× 70 0.7× 70 0.9× 35 1.0× 24 374
Régine Romi‐Lebrun France 10 520 1.3× 64 0.6× 312 3.2× 27 0.4× 4 0.1× 10 559
Juliano R. Guerreiro Brazil 10 264 0.7× 47 0.4× 228 2.3× 82 1.1× 19 0.5× 15 426
Albert Tseng Australia 9 381 1.0× 12 0.1× 60 0.6× 151 2.0× 14 0.4× 22 561

Countries citing papers authored by Mark D. Lanigan

Since Specialization
Citations

This map shows the geographic impact of Mark D. Lanigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Lanigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Lanigan more than expected).

Fields of papers citing papers by Mark D. Lanigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Lanigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Lanigan. The network helps show where Mark D. Lanigan may publish in the future.

Co-authorship network of co-authors of Mark D. Lanigan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Lanigan. A scholar is included among the top collaborators of Mark D. Lanigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Lanigan. Mark D. Lanigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Egan, Sharon A., Mark D. Lanigan, Brian J. Shiell, et al.. (2008). The recovery of Mycobacterium avium subspecies paratuberculosis from the intestine of infected ruminants for proteomic evaluation. Journal of Microbiological Methods. 75(1). 29–39. 10 indexed citations
2.
Lanigan, Mark D., Brian J. Shiell, K. Bruce, et al.. (2007). Secreted antigens of Mycobacterium avium subsp. paratuberculosis: identity, characterisation, expression profiles and immunoreactivity.. 67–79. 2 indexed citations
3.
Lanigan, Mark D., et al.. (2004). Mycobacterial proteome extraction: Comparison of disruption methods. PROTEOMICS. 4(4). 1094–1100. 26 indexed citations
5.
Lanigan, Mark D., et al.. (2001). A helical capping motif in ShK toxin and its role in helix stabilization. Biopolymers. 58(4). 422–436. 9 indexed citations
6.
Lanigan, Mark D., et al.. (2001). Designed Peptide Analogues of the Potassium Channel Blocker ShK Toxin. Biochemistry. 40(51). 15528–15537. 16 indexed citations
7.
Rauer, Heiko, Mark D. Lanigan, Michael W. Pennington, et al.. (2000). Structure-guided Transformation of Charybdotoxin Yields an Analog That Selectively Targets Ca2+-activated over Voltage-gated K+ Channels. Journal of Biological Chemistry. 275(2). 1201–1208. 100 indexed citations
8.
Pennington, Michael W., Mark D. Lanigan, Katalin Kálmán, et al.. (1999). Role of Disulfide Bonds in the Structure and Potassium Channel Blocking Activity of ShK Toxin. Biochemistry. 38(44). 14549–14558. 28 indexed citations
9.
Kálmán, Katalin, Michael W. Pennington, Mark D. Lanigan, et al.. (1998). ShK-Dap22, a Potent Kv1.3-specific Immunosuppressive Polypeptide. Journal of Biological Chemistry. 273(49). 32697–32707. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026